TABLE 2.
No.a | Specimen typee | Pregnant | Age | Racef | Obesityb | Underlying disease(s)g | Peripartum antibiotic prophylaxis | S. pseudoporcinus clinical infection |
---|---|---|---|---|---|---|---|---|
1 | Cervix | Yes | 28 | AA | No | Smoking | Cefazolin | No |
2 | Vagina | Yes | 29 | AA | Yesc | History of UTI, TV | Ceftriaxone | Fever during delivery, suspected neonatal infection |
3d | Vagina | Yes | 37 | AA | No | No | Penicillin | No |
4 | Vagina | Yes | 28 | AA | Yes | Smoking, history of HSV | Clindamycin | No |
5 | Vagina | Yes | 25 | AA | No | NA | NA | NA |
6 | Vagina | Yes | 44 | AA | Yesc | History of CT | Penicillin | No |
7 | Vagina | Yes | 21 | W | Yesc | Smoking | Cefazolin | No |
8 | Vagina | Yes | 33 | AA | Yesc | DM | Penicillin | No |
9d | Vagina | Yes | 27 | AA | Yes | No | No | Fever during delivery, suspected neonatal infection |
10 | Vagina | Yes | 29 | AA | Yes | No | No | No |
11 | Vagina | Yes | 28 | AA | Yes | No | Penicillin | No |
12 | Vagina | Yes | 27 | AA | Yesc | DM | No | No |
13 | Vagina | Yes | 30 | AA | Yesc | DM, smoking, history of HSV | Cefazolin | No |
14 | Vagina | Yes | 27 | AA | Yes | DM, history of HSV | No | No |
15d | Vagina | Yes | 23 | AA | Yes | Smoking | Clindamycin | No |
16d | Vagina | Yes | 21 | AA | No | Smoking, history of UTI, CT, BV | Ampicillin, gentamicin | Fever during delivery, suspected neonatal infection |
17d | Vagina | Yes | 18 | AA | No | No | No | No |
18 | Vagina | Yes | 23 | AA | No | History of GC, CT, BV | Cefazolin | No |
19d | Vagina | Yes | 30 | AA | Yes | History of GC, CT | Penicillin | No |
20d | Vagina | Yes | 24 | AA | Yesc | History of GC, CT | Penicillin, cefazolin | No |
21d | Vagina | Yes | 26 | AA | No | DM | Penicillin, cefazolin | No |
22 | Vagina | Yes | 25 | AA | Yesc | History of CT | Penicillin | No |
23 | Vagina | Yes | 25 | AA | Yesc | UTI | Cefazolin | No |
24 | Vagina | Yes | 26 | AA | Yes | Smoking, history of GC, TV | Penicillin, cefazolin | Fever during delivery, suspected neonatal infection |
25d | Vagina | Yes | 26 | AA | Yesc | Premature ruptured membranes | Penicillin, cefazolin | No |
26 | Cervix | No | 27 | AA | No | No | NA | Vaginitis, UTI |
27 | Vagina | No | 24 | AA | No | No | NA | Vaginitis |
28d | Vagina | No | 26 | AA | No | History of GC | NA | Vaginitis, positive GC NAAT |
29d | Vagina | No | 23 | AA | No | No | NA | Vaginitis |
30 | Cervix | No | 39 | AA | No | History of BV | NA | Vaginitis |
31d | Vagina | No | 25 | NA | No | NA | Vaginitis and dyspareunia | |
32d | Vagina | No | 21 | AA | No | No | NA | Vaginitis and Trichomonas infection |
33 | Urine | No | 32 | W | NA | Multiple sclerosis, recurrent UTI | NA | UTI, hematuria, urine culture grew E. coli and S. pseudoporcinus |
34 | Wound | No | 50 | AA | NA | DM, endometrial cancer | NA | Posthysterectomy with fever, pelvic abscess with mixed infection |
Thirty-two S. pseudoporcinus isolates were recovered from female genital sources, and two S. pseudoporcinus isolates were from nongenital sources (urine culture and posthysterectomy wound culture).
Obesity was defined as a prepregnancy body mass index of ≥30.
Morbid obesity was defined as a prepregnancy body mass index of ≥40.
Using the JHH microbiology laboratory GBS screening and identification protocol, we reported a positive GBS screening result if the isolates were found to carry the B antigen by the Prolex test.
Vagina, vaginal-rectal sample.
AA, African American; W, white.
NA, data not available; BV, bacterial vaginosis; CT, C. trachomatis infection; DM, diabetes mellitus; GC, gonococcal infection; HSV, herpes simplex virus infection (genital herpes); NAAT, nucleic acid amplification test; TV, T. vaginalis infection.